We provide you with 20 years of free, institutional-grade data for AYTU stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AYTU. Explore the full financial landscape of AYTU stock.
| Reported Date | CIK | Ticker | Type |
|---|
Aytu Biopharma, Inc(NASDAQ:AYTU) 
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Nates...
Website: http://aytubio.com
Founded: 2002
Full Time Employees: 75
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about AYTU stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.